NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/08/2025
Back to search
Official data from USPTO
TILDA RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TILDA RESEARCH
ST13
US500000098297730Class
35, 42
Filing
98297730
Registration
7750119
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
04/08/2025
Trademark type
Word
Nice classes
35, 42
Filing date
12/04/2023
Registration date
04/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/08/2025
Last transaction
04/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/25/2019
First use in commerce
06/25/2019
Drawing code
4
Owner type
03
Owner location
Tustin, CA, US
Examiner
FRUM MILONE, MARCIE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Tilda Research, Inc.
Representatives
Ryan Roberts
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsproviding information management servicesrecordkeepingworkflowsquery management
Class 42
Providing information in the field of clinical research via a website; Consulting services for others in the field of designplanningimplementation project management of clinical trialsincluding query management; Platform as a service (PAAS) featuring computer software platforms for use in runningmanaging and analyzing clinical trialsenabling providers to create and scale clinical research capabilities and bring scientific advancements to patients; Platform as a service (PAAS) featuring computer software platforms for use in manage and/or participate in clinical researchquery management and view data analytics; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research personnel to run clinical trials; Providing a website featuring non-downloadable software for use in clinical research analytics and data capture forms; Providing medical and scientific research information in the field of clinical trials
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/18/2025
PUBO
PUBLISHED FOR OPPOSITION
02/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2025
NREV
NOTICE OF REVIVAL - E-MAILED
01/23/2025
PETG
PETITION TO REVIVE-GRANTED
01/23/2025
PROA
TEAS PETITION TO REVIVE RECEIVED
01/23/2025
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
12/04/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
12/04/2024
DOCK
ASSIGNED TO EXAMINER
10/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/03/2024
GNRT
NON-FINAL ACTION E-MAILED
07/03/2024
CNRT
NON-FINAL ACTION WRITTEN
07/03/2024
DOCK
ASSIGNED TO EXAMINER
07/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2024
NWAP
NEW APPLICATION ENTERED
12/04/2023
Continuous trademark protection
Get notified about every new filing that threatens TILDA RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.